IBDEI0D6 ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,33057,1,3,0)
;;=3^Neopl,Unspec Behav,Right Kidney
;;^UTILITY(U,$J,358.3,33057,1,4,0)
;;=4^D49.511
;;^UTILITY(U,$J,358.3,33057,2)
;;=^5138160
;;^UTILITY(U,$J,358.3,33058,0)
;;=D49.512^^102^1377^9
;;^UTILITY(U,$J,358.3,33058,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33058,1,3,0)
;;=3^Neopl,Unspec Behav,Left Kidney
;;^UTILITY(U,$J,358.3,33058,1,4,0)
;;=4^D49.512
;;^UTILITY(U,$J,358.3,33058,2)
;;=^5138161
;;^UTILITY(U,$J,358.3,33059,0)
;;=Z48.22^^102^1377^2
;;^UTILITY(U,$J,358.3,33059,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33059,1,3,0)
;;=3^Aftercare Following Kidney Transplant
;;^UTILITY(U,$J,358.3,33059,1,4,0)
;;=4^Z48.22
;;^UTILITY(U,$J,358.3,33059,2)
;;=^5063039
;;^UTILITY(U,$J,358.3,33060,0)
;;=Z94.83^^102^1377^11
;;^UTILITY(U,$J,358.3,33060,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33060,1,3,0)
;;=3^Pancreas Transplant Status
;;^UTILITY(U,$J,358.3,33060,1,4,0)
;;=4^Z94.83
;;^UTILITY(U,$J,358.3,33060,2)
;;=^5063664
;;^UTILITY(U,$J,358.3,33061,0)
;;=B17.11^^102^1378^2
;;^UTILITY(U,$J,358.3,33061,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33061,1,3,0)
;;=3^Acute hepatitis C with hepatic coma
;;^UTILITY(U,$J,358.3,33061,1,4,0)
;;=4^B17.11
;;^UTILITY(U,$J,358.3,33061,2)
;;=^331777
;;^UTILITY(U,$J,358.3,33062,0)
;;=B18.2^^102^1378^10
;;^UTILITY(U,$J,358.3,33062,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33062,1,3,0)
;;=3^Chronic viral hepatitis C
;;^UTILITY(U,$J,358.3,33062,1,4,0)
;;=4^B18.2
;;^UTILITY(U,$J,358.3,33062,2)
;;=^5000548
;;^UTILITY(U,$J,358.3,33063,0)
;;=B17.10^^102^1378^3
;;^UTILITY(U,$J,358.3,33063,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33063,1,3,0)
;;=3^Acute hepatitis C without hepatic coma
;;^UTILITY(U,$J,358.3,33063,1,4,0)
;;=4^B17.10
;;^UTILITY(U,$J,358.3,33063,2)
;;=^5000542
;;^UTILITY(U,$J,358.3,33064,0)
;;=B19.20^^102^1378^24
;;^UTILITY(U,$J,358.3,33064,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33064,1,3,0)
;;=3^Viral hepatitis C without hepatic coma,Unspec
;;^UTILITY(U,$J,358.3,33064,1,4,0)
;;=4^B19.20
;;^UTILITY(U,$J,358.3,33064,2)
;;=^331436
;;^UTILITY(U,$J,358.3,33065,0)
;;=B19.21^^102^1378^23
;;^UTILITY(U,$J,358.3,33065,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33065,1,3,0)
;;=3^Viral hepatitis C with hepatic coma,Unspec
;;^UTILITY(U,$J,358.3,33065,1,4,0)
;;=4^B19.21
;;^UTILITY(U,$J,358.3,33065,2)
;;=^331437
;;^UTILITY(U,$J,358.3,33066,0)
;;=C22.0^^102^1378^16
;;^UTILITY(U,$J,358.3,33066,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33066,1,3,0)
;;=3^Liver cell carcinoma
;;^UTILITY(U,$J,358.3,33066,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,33066,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,33067,0)
;;=C22.7^^102^1378^8
;;^UTILITY(U,$J,358.3,33067,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33067,1,3,0)
;;=3^Carcinomas of liver NEC
;;^UTILITY(U,$J,358.3,33067,1,4,0)
;;=4^C22.7
;;^UTILITY(U,$J,358.3,33067,2)
;;=^5000938
;;^UTILITY(U,$J,358.3,33068,0)
;;=C22.8^^102^1378^19
;;^UTILITY(U,$J,358.3,33068,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33068,1,3,0)
;;=3^Malignant neoplasm of liver, primary
;;^UTILITY(U,$J,358.3,33068,1,4,0)
;;=4^C22.8
;;^UTILITY(U,$J,358.3,33068,2)
;;=^5000939
;;^UTILITY(U,$J,358.3,33069,0)
;;=C22.1^^102^1378^14
;;^UTILITY(U,$J,358.3,33069,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33069,1,3,0)
;;=3^Intrahepatic bile duct carcinoma
;;^UTILITY(U,$J,358.3,33069,1,4,0)
;;=4^C22.1
;;^UTILITY(U,$J,358.3,33069,2)
;;=^5000934
;;^UTILITY(U,$J,358.3,33070,0)
;;=C22.9^^102^1378^18
;;^UTILITY(U,$J,358.3,33070,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33070,1,3,0)
;;=3^Malignant neoplasm of liver
;;^UTILITY(U,$J,358.3,33070,1,4,0)
;;=4^C22.9
;;^UTILITY(U,$J,358.3,33070,2)
;;=^267096
;;^UTILITY(U,$J,358.3,33071,0)
;;=C78.7^^102^1378^22
;;^UTILITY(U,$J,358.3,33071,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33071,1,3,0)
;;=3^Secondary malig neoplasm of liver and intrahepatic bile duct
;;^UTILITY(U,$J,358.3,33071,1,4,0)
;;=4^C78.7
;;^UTILITY(U,$J,358.3,33071,2)
;;=^5001339
;;^UTILITY(U,$J,358.3,33072,0)
;;=K74.60^^102^1378^12
;;^UTILITY(U,$J,358.3,33072,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33072,1,3,0)
;;=3^Cirrhosis of liver,Unspec
;;^UTILITY(U,$J,358.3,33072,1,4,0)
;;=4^K74.60
;;^UTILITY(U,$J,358.3,33072,2)
;;=^5008822
;;^UTILITY(U,$J,358.3,33073,0)
;;=K76.0^^102^1378^13
;;^UTILITY(U,$J,358.3,33073,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33073,1,3,0)
;;=3^Fatty (change of) liver, not elsewhere classified
;;^UTILITY(U,$J,358.3,33073,1,4,0)
;;=4^K76.0
;;^UTILITY(U,$J,358.3,33073,2)
;;=^5008831
;;^UTILITY(U,$J,358.3,33074,0)
;;=K76.89^^102^1378^15
;;^UTILITY(U,$J,358.3,33074,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33074,1,3,0)
;;=3^Liver Disease NEC
;;^UTILITY(U,$J,358.3,33074,1,4,0)
;;=4^K76.89
;;^UTILITY(U,$J,358.3,33074,2)
;;=^5008835
;;^UTILITY(U,$J,358.3,33075,0)
;;=K70.30^^102^1378^6
;;^UTILITY(U,$J,358.3,33075,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33075,1,3,0)
;;=3^Alcoholic cirrhosis of liver without ascites
;;^UTILITY(U,$J,358.3,33075,1,4,0)
;;=4^K70.30
;;^UTILITY(U,$J,358.3,33075,2)
;;=^5008788
;;^UTILITY(U,$J,358.3,33076,0)
;;=K70.31^^102^1378^5
;;^UTILITY(U,$J,358.3,33076,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33076,1,3,0)
;;=3^Alcoholic cirrhosis of liver with ascites
;;^UTILITY(U,$J,358.3,33076,1,4,0)
;;=4^K70.31
;;^UTILITY(U,$J,358.3,33076,2)
;;=^5008789
;;^UTILITY(U,$J,358.3,33077,0)
;;=K75.4^^102^1378^7
;;^UTILITY(U,$J,358.3,33077,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33077,1,3,0)
;;=3^Autoimmune hepatitis
;;^UTILITY(U,$J,358.3,33077,1,4,0)
;;=4^K75.4
;;^UTILITY(U,$J,358.3,33077,2)
;;=^336610
;;^UTILITY(U,$J,358.3,33078,0)
;;=K74.69^^102^1378^11
;;^UTILITY(U,$J,358.3,33078,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33078,1,3,0)
;;=3^Cirrhosis of liver NEC
;;^UTILITY(U,$J,358.3,33078,1,4,0)
;;=4^K74.69
;;^UTILITY(U,$J,358.3,33078,2)
;;=^5008823
;;^UTILITY(U,$J,358.3,33079,0)
;;=K74.3^^102^1378^21
;;^UTILITY(U,$J,358.3,33079,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33079,1,3,0)
;;=3^Primary biliary cirrhosis
;;^UTILITY(U,$J,358.3,33079,1,4,0)
;;=4^K74.3
;;^UTILITY(U,$J,358.3,33079,2)
;;=^5008819
;;^UTILITY(U,$J,358.3,33080,0)
;;=K75.81^^102^1378^20
;;^UTILITY(U,$J,358.3,33080,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33080,1,3,0)
;;=3^Nonalcoholic steatohepatitis (NASH)
;;^UTILITY(U,$J,358.3,33080,1,4,0)
;;=4^K75.81
;;^UTILITY(U,$J,358.3,33080,2)
;;=K830^5008828
;;^UTILITY(U,$J,358.3,33081,0)
;;=B16.9^^102^1378^1
;;^UTILITY(U,$J,358.3,33081,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33081,1,3,0)
;;=3^Acute hepatitis B w/o delta-agent and without hepatic coma
;;^UTILITY(U,$J,358.3,33081,1,4,0)
;;=4^B16.9
;;^UTILITY(U,$J,358.3,33081,2)
;;=^5000540
;;^UTILITY(U,$J,358.3,33082,0)
;;=B18.1^^102^1378^9
;;^UTILITY(U,$J,358.3,33082,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33082,1,3,0)
;;=3^Chronic viral hepatitis B without delta-agent
;;^UTILITY(U,$J,358.3,33082,1,4,0)
;;=4^B18.1
;;^UTILITY(U,$J,358.3,33082,2)
;;=^5000547
;;^UTILITY(U,$J,358.3,33083,0)
;;=Z94.4^^102^1378^17
;;^UTILITY(U,$J,358.3,33083,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33083,1,3,0)
;;=3^Liver transplant status
;;^UTILITY(U,$J,358.3,33083,1,4,0)
;;=4^Z94.4
;;^UTILITY(U,$J,358.3,33083,2)
;;=^5063658
;;^UTILITY(U,$J,358.3,33084,0)
;;=Z48.23^^102^1378^4
;;^UTILITY(U,$J,358.3,33084,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33084,1,3,0)
;;=3^Aftercare Following Liver Transplant
;;^UTILITY(U,$J,358.3,33084,1,4,0)
;;=4^Z48.23
;;^UTILITY(U,$J,358.3,33084,2)
;;=^5063040
;;^UTILITY(U,$J,358.3,33085,0)
;;=J90.^^102^1379^16
;;^UTILITY(U,$J,358.3,33085,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33085,1,3,0)
;;=3^Pleural effusion, not elsewhere classified
;;^UTILITY(U,$J,358.3,33085,1,4,0)
;;=4^J90.
;;^UTILITY(U,$J,358.3,33085,2)
;;=^5008310
;;^UTILITY(U,$J,358.3,33086,0)
;;=C34.91^^102^1379^13
;;^UTILITY(U,$J,358.3,33086,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33086,1,3,0)
;;=3^Malignant neoplasm of unsp part of right bronchus or lung
;;^UTILITY(U,$J,358.3,33086,1,4,0)
;;=4^C34.91
;;^UTILITY(U,$J,358.3,33086,2)
;;=^5000967
;;^UTILITY(U,$J,358.3,33087,0)
;;=C34.92^^102^1379^12
;;^UTILITY(U,$J,358.3,33087,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33087,1,3,0)
;;=3^Malignant neoplasm of unsp part of left bronchus or lung
;;^UTILITY(U,$J,358.3,33087,1,4,0)
;;=4^C34.92
;;^UTILITY(U,$J,358.3,33087,2)
;;=^5000968
;;^UTILITY(U,$J,358.3,33088,0)
;;=C34.01^^102^1379^11
;;^UTILITY(U,$J,358.3,33088,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33088,1,3,0)
;;=3^Malignant neoplasm of right main bronchus
;;^UTILITY(U,$J,358.3,33088,1,4,0)
;;=4^C34.01
;;^UTILITY(U,$J,358.3,33088,2)
;;=^5000958
;;^UTILITY(U,$J,358.3,33089,0)
;;=C34.02^^102^1379^5
;;^UTILITY(U,$J,358.3,33089,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33089,1,3,0)
;;=3^Malignant neoplasm of left main bronchus
;;^UTILITY(U,$J,358.3,33089,1,4,0)
;;=4^C34.02
;;^UTILITY(U,$J,358.3,33089,2)
;;=^5000959
;;^UTILITY(U,$J,358.3,33090,0)
;;=C34.11^^102^1379^15
;;^UTILITY(U,$J,358.3,33090,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33090,1,3,0)
;;=3^Malignant neoplasm of upper lobe, right bronchus or lung
;;^UTILITY(U,$J,358.3,33090,1,4,0)
;;=4^C34.11
;;^UTILITY(U,$J,358.3,33090,2)
;;=^5000961
;;^UTILITY(U,$J,358.3,33091,0)
;;=C34.12^^102^1379^14
;;^UTILITY(U,$J,358.3,33091,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33091,1,3,0)
;;=3^Malignant neoplasm of upper lobe, left bronchus or lung
;;^UTILITY(U,$J,358.3,33091,1,4,0)
;;=4^C34.12
;;^UTILITY(U,$J,358.3,33091,2)
;;=^5000962
;;^UTILITY(U,$J,358.3,33092,0)
;;=C34.2^^102^1379^8
;;^UTILITY(U,$J,358.3,33092,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33092,1,3,0)
;;=3^Malignant neoplasm of middle lobe, bronchus or lung
;;^UTILITY(U,$J,358.3,33092,1,4,0)
;;=4^C34.2
;;^UTILITY(U,$J,358.3,33092,2)
;;=^267137
;;^UTILITY(U,$J,358.3,33093,0)
;;=C34.31^^102^1379^7
;;^UTILITY(U,$J,358.3,33093,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33093,1,3,0)
;;=3^Malignant neoplasm of lower lobe, right bronchus or lung
;;^UTILITY(U,$J,358.3,33093,1,4,0)
;;=4^C34.31
;;^UTILITY(U,$J,358.3,33093,2)
;;=^5133321
;;^UTILITY(U,$J,358.3,33094,0)
;;=C34.32^^102^1379^6
;;^UTILITY(U,$J,358.3,33094,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33094,1,3,0)
;;=3^Malignant neoplasm of lower lobe, left bronchus or lung
;;^UTILITY(U,$J,358.3,33094,1,4,0)
;;=4^C34.32
;;^UTILITY(U,$J,358.3,33094,2)
;;=^5133322
;;^UTILITY(U,$J,358.3,33095,0)
;;=C34.81^^102^1379^10
;;^UTILITY(U,$J,358.3,33095,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33095,1,3,0)
;;=3^Malignant neoplasm of ovrlp sites of right bronchus and lung
;;^UTILITY(U,$J,358.3,33095,1,4,0)
;;=4^C34.81
;;^UTILITY(U,$J,358.3,33095,2)
;;=^5000964
;;^UTILITY(U,$J,358.3,33096,0)
;;=C34.82^^102^1379^9
;;^UTILITY(U,$J,358.3,33096,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33096,1,3,0)
;;=3^Malignant neoplasm of ovrlp sites of left bronchus and lung
;;^UTILITY(U,$J,358.3,33096,1,4,0)
;;=4^C34.82
;;^UTILITY(U,$J,358.3,33096,2)
;;=^5000965
;;^UTILITY(U,$J,358.3,33097,0)
;;=Z48.24^^102^1379^2
;;^UTILITY(U,$J,358.3,33097,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33097,1,3,0)
;;=3^Aftercare Following Lung Transplant
;;^UTILITY(U,$J,358.3,33097,1,4,0)
;;=4^Z48.24
;;^UTILITY(U,$J,358.3,33097,2)
;;=^5063041
;;^UTILITY(U,$J,358.3,33098,0)
;;=Z48.280^^102^1379^1
;;^UTILITY(U,$J,358.3,33098,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33098,1,3,0)
;;=3^Aftercare Following Heart & Lung Transplant
;;^UTILITY(U,$J,358.3,33098,1,4,0)
;;=4^Z48.280
;;^UTILITY(U,$J,358.3,33098,2)
;;=^5063042
;;^UTILITY(U,$J,358.3,33099,0)
;;=Z94.3^^102^1379^3
;;^UTILITY(U,$J,358.3,33099,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33099,1,3,0)
;;=3^Heart & Lungs Transplant Status
;;^UTILITY(U,$J,358.3,33099,1,4,0)
;;=4^Z94.3
;;^UTILITY(U,$J,358.3,33099,2)
;;=^5063657
;;^UTILITY(U,$J,358.3,33100,0)
;;=Z94.2^^102^1379^4
;;^UTILITY(U,$J,358.3,33100,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33100,1,3,0)
;;=3^Lung Transplant Status
;;^UTILITY(U,$J,358.3,33100,1,4,0)
;;=4^Z94.2
;;^UTILITY(U,$J,358.3,33100,2)
;;=^5063656
;;^UTILITY(U,$J,358.3,33101,0)
;;=C83.38^^102^1380^22
;;^UTILITY(U,$J,358.3,33101,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33101,1,3,0)
;;=3^Diffuse large B-cell lymphoma, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33101,1,4,0)
;;=4^C83.38
;;^UTILITY(U,$J,358.3,33101,2)
;;=^5001579
;;^UTILITY(U,$J,358.3,33102,0)
;;=C83.58^^102^1380^28
;;^UTILITY(U,$J,358.3,33102,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33102,1,3,0)
;;=3^Lymphoblastic (diffuse) lymphoma, lymph nodes mult site
;;^UTILITY(U,$J,358.3,33102,1,4,0)
;;=4^C83.58
;;^UTILITY(U,$J,358.3,33102,2)
;;=^5001589
;;^UTILITY(U,$J,358.3,33103,0)
;;=C83.78^^102^1380^15
;;^UTILITY(U,$J,358.3,33103,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33103,1,3,0)
;;=3^Burkitt lymphoma, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33103,1,4,0)
;;=4^C83.78
;;^UTILITY(U,$J,358.3,33103,2)
;;=^5001599
;;^UTILITY(U,$J,358.3,33104,0)
;;=C83.18^^102^1380^34
;;^UTILITY(U,$J,358.3,33104,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33104,1,3,0)
;;=3^Mantle cell lymphoma, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33104,1,4,0)
;;=4^C83.18
;;^UTILITY(U,$J,358.3,33104,2)
;;=^5001569
;;^UTILITY(U,$J,358.3,33105,0)
;;=C84.68^^102^1380^12
;;^UTILITY(U,$J,358.3,33105,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33105,1,3,0)
;;=3^Anaplastic large cell lymphoma, ALK-pos, nodes mult site
;;^UTILITY(U,$J,358.3,33105,1,4,0)
;;=4^C84.68
;;^UTILITY(U,$J,358.3,33105,2)
;;=^5001659
;;^UTILITY(U,$J,358.3,33106,0)
;;=C84.78^^102^1380^11
;;^UTILITY(U,$J,358.3,33106,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33106,1,3,0)
;;=3^Anaplastic large cell lymphoma, ALK-neg, nodes mult site
;;^UTILITY(U,$J,358.3,33106,1,4,0)
;;=4^C84.78
;;^UTILITY(U,$J,358.3,33106,2)
;;=^5001669
;;^UTILITY(U,$J,358.3,33107,0)
;;=C81.08^^102^1380^47
;;^UTILITY(U,$J,358.3,33107,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33107,1,3,0)
;;=3^Nodular lymphocyte predom Hodgkin lymphoma, nodes mult site
;;^UTILITY(U,$J,358.3,33107,1,4,0)
;;=4^C81.08
;;^UTILITY(U,$J,358.3,33107,2)
;;=^5001399
;;^UTILITY(U,$J,358.3,33108,0)
;;=C81.48^^102^1380^27
;;^UTILITY(U,$J,358.3,33108,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33108,1,3,0)
;;=3^Lymp-rich classical Hodgkin lymphoma, lymph nodes mult site
;;^UTILITY(U,$J,358.3,33108,1,4,0)
;;=4^C81.48
;;^UTILITY(U,$J,358.3,33108,2)
;;=^5001439
;;^UTILITY(U,$J,358.3,33109,0)
;;=C81.18^^102^1380^48
;;^UTILITY(U,$J,358.3,33109,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33109,1,3,0)
;;=3^Nodular sclerosis class Hodgkin lymphoma, nodes mult site
;;^UTILITY(U,$J,358.3,33109,1,4,0)
;;=4^C81.18
;;^UTILITY(U,$J,358.3,33109,2)
;;=^5001409
;;^UTILITY(U,$J,358.3,33110,0)
;;=C81.28^^102^1380^38
;;^UTILITY(U,$J,358.3,33110,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33110,1,3,0)
;;=3^Mixed cellular classical Hodgkin lymphoma, nodes mult site
;;^UTILITY(U,$J,358.3,33110,1,4,0)
;;=4^C81.28
;;^UTILITY(U,$J,358.3,33110,2)
;;=^5001419
;;^UTILITY(U,$J,358.3,33111,0)
;;=C81.38^^102^1380^29
;;^UTILITY(U,$J,358.3,33111,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33111,1,3,0)
;;=3^Lymphocy depleted class Hodgkin lymphoma, nodes mult site
;;^UTILITY(U,$J,358.3,33111,1,4,0)
;;=4^C81.38
;;^UTILITY(U,$J,358.3,33111,2)
;;=^5001429
;;^UTILITY(U,$J,358.3,33112,0)
;;=C82.98^^102^1380^25
;;^UTILITY(U,$J,358.3,33112,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33112,1,3,0)
;;=3^Follicular lymphoma, unsp, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33112,1,4,0)
;;=4^C82.98
;;^UTILITY(U,$J,358.3,33112,2)
;;=^5001549
;;^UTILITY(U,$J,358.3,33113,0)
;;=C84.08^^102^1380^44
;;^UTILITY(U,$J,358.3,33113,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33113,1,3,0)
;;=3^Mycosis fungoides, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33113,1,4,0)
;;=4^C84.08
;;^UTILITY(U,$J,358.3,33113,2)
;;=^5001629
;;^UTILITY(U,$J,358.3,33114,0)
;;=C84.18^^102^1380^53
;;^UTILITY(U,$J,358.3,33114,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33114,1,3,0)
;;=3^Sezary disease, lymph nodes of multiple sites
;;^UTILITY(U,$J,358.3,33114,1,4,0)
;;=4^C84.18
;;^UTILITY(U,$J,358.3,33114,2)
;;=^5001639
;;^UTILITY(U,$J,358.3,33115,0)
;;=C91.40^^102^1380^26
;;^UTILITY(U,$J,358.3,33115,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33115,1,3,0)
;;=3^Hairy cell leukemia not having achieved remission
;;^UTILITY(U,$J,358.3,33115,1,4,0)
;;=4^C91.40
;;^UTILITY(U,$J,358.3,33115,2)
;;=^5001771
;;^UTILITY(U,$J,358.3,33116,0)
;;=C96.0^^102^1380^41
;;^UTILITY(U,$J,358.3,33116,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33116,1,3,0)
;;=3^Multifocal and multisystemic Langerhans-cell histiocytosis
;;^UTILITY(U,$J,358.3,33116,1,4,0)
;;=4^C96.0
;;^UTILITY(U,$J,358.3,33116,2)
;;=^5001859
;;^UTILITY(U,$J,358.3,33117,0)
;;=C84.48^^102^1380^49
;;^UTILITY(U,$J,358.3,33117,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33117,1,3,0)
;;=3^Peripheral T-cell lymphoma, not classified, nodes mult site
;;^UTILITY(U,$J,358.3,33117,1,4,0)
;;=4^C84.48
;;^UTILITY(U,$J,358.3,33117,2)
;;=^5001649
;;^UTILITY(U,$J,358.3,33118,0)
;;=C90.01^^102^1380^43
;;^UTILITY(U,$J,358.3,33118,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33118,1,3,0)
;;=3^Multiple myeloma in remission
;;^UTILITY(U,$J,358.3,33118,1,4,0)
;;=4^C90.01
;;^UTILITY(U,$J,358.3,33118,2)
;;=^267515
;;^UTILITY(U,$J,358.3,33119,0)
;;=C90.02^^102^1380^42
;;^UTILITY(U,$J,358.3,33119,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33119,1,3,0)
;;=3^Multiple myeloma in relapse
;;^UTILITY(U,$J,358.3,33119,1,4,0)
;;=4^C90.02
;;^UTILITY(U,$J,358.3,33119,2)
;;=^5001753
;;^UTILITY(U,$J,358.3,33120,0)
;;=C90.11^^102^1380^51
;;^UTILITY(U,$J,358.3,33120,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33120,1,3,0)
;;=3^Plasma cell leukemia in remission
;;^UTILITY(U,$J,358.3,33120,1,4,0)
;;=4^C90.11
;;^UTILITY(U,$J,358.3,33120,2)
;;=^267517
;;^UTILITY(U,$J,358.3,33121,0)
;;=C90.12^^102^1380^50
;;^UTILITY(U,$J,358.3,33121,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33121,1,3,0)
;;=3^Plasma cell leukemia in relapse
;;^UTILITY(U,$J,358.3,33121,1,4,0)
;;=4^C90.12
;;^UTILITY(U,$J,358.3,33121,2)
;;=^5001755
;;^UTILITY(U,$J,358.3,33122,0)
;;=C90.21^^102^1380^24
;;^UTILITY(U,$J,358.3,33122,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,33122,1,3,0)
;;=3^Extramedullary plasmacytoma in remission
;;^UTILITY(U,$J,358.3,33122,1,4,0)
;;=4^C90.21
;;^UTILITY(U,$J,358.3,33122,2)
;;=^5001757
;;^UTILITY(U,$J,358.3,33123,0)
;;=C90.31^^102^1380^55
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0D6 19771 printed Sep 23, 2025@19:22:20 Page 2
IBDEI0D6 ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,33057,1,3,0)
+2 ;;=3^Neopl,Unspec Behav,Right Kidney
+3 ;;^UTILITY(U,$J,358.3,33057,1,4,0)
+4 ;;=4^D49.511
+5 ;;^UTILITY(U,$J,358.3,33057,2)
+6 ;;=^5138160
+7 ;;^UTILITY(U,$J,358.3,33058,0)
+8 ;;=D49.512^^102^1377^9
+9 ;;^UTILITY(U,$J,358.3,33058,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,33058,1,3,0)
+12 ;;=3^Neopl,Unspec Behav,Left Kidney
+13 ;;^UTILITY(U,$J,358.3,33058,1,4,0)
+14 ;;=4^D49.512
+15 ;;^UTILITY(U,$J,358.3,33058,2)
+16 ;;=^5138161
+17 ;;^UTILITY(U,$J,358.3,33059,0)
+18 ;;=Z48.22^^102^1377^2
+19 ;;^UTILITY(U,$J,358.3,33059,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,33059,1,3,0)
+22 ;;=3^Aftercare Following Kidney Transplant
+23 ;;^UTILITY(U,$J,358.3,33059,1,4,0)
+24 ;;=4^Z48.22
+25 ;;^UTILITY(U,$J,358.3,33059,2)
+26 ;;=^5063039
+27 ;;^UTILITY(U,$J,358.3,33060,0)
+28 ;;=Z94.83^^102^1377^11
+29 ;;^UTILITY(U,$J,358.3,33060,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,33060,1,3,0)
+32 ;;=3^Pancreas Transplant Status
+33 ;;^UTILITY(U,$J,358.3,33060,1,4,0)
+34 ;;=4^Z94.83
+35 ;;^UTILITY(U,$J,358.3,33060,2)
+36 ;;=^5063664
+37 ;;^UTILITY(U,$J,358.3,33061,0)
+38 ;;=B17.11^^102^1378^2
+39 ;;^UTILITY(U,$J,358.3,33061,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,33061,1,3,0)
+42 ;;=3^Acute hepatitis C with hepatic coma
+43 ;;^UTILITY(U,$J,358.3,33061,1,4,0)
+44 ;;=4^B17.11
+45 ;;^UTILITY(U,$J,358.3,33061,2)
+46 ;;=^331777
+47 ;;^UTILITY(U,$J,358.3,33062,0)
+48 ;;=B18.2^^102^1378^10
+49 ;;^UTILITY(U,$J,358.3,33062,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,33062,1,3,0)
+52 ;;=3^Chronic viral hepatitis C
+53 ;;^UTILITY(U,$J,358.3,33062,1,4,0)
+54 ;;=4^B18.2
+55 ;;^UTILITY(U,$J,358.3,33062,2)
+56 ;;=^5000548
+57 ;;^UTILITY(U,$J,358.3,33063,0)
+58 ;;=B17.10^^102^1378^3
+59 ;;^UTILITY(U,$J,358.3,33063,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,33063,1,3,0)
+62 ;;=3^Acute hepatitis C without hepatic coma
+63 ;;^UTILITY(U,$J,358.3,33063,1,4,0)
+64 ;;=4^B17.10
+65 ;;^UTILITY(U,$J,358.3,33063,2)
+66 ;;=^5000542
+67 ;;^UTILITY(U,$J,358.3,33064,0)
+68 ;;=B19.20^^102^1378^24
+69 ;;^UTILITY(U,$J,358.3,33064,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,33064,1,3,0)
+72 ;;=3^Viral hepatitis C without hepatic coma,Unspec
+73 ;;^UTILITY(U,$J,358.3,33064,1,4,0)
+74 ;;=4^B19.20
+75 ;;^UTILITY(U,$J,358.3,33064,2)
+76 ;;=^331436
+77 ;;^UTILITY(U,$J,358.3,33065,0)
+78 ;;=B19.21^^102^1378^23
+79 ;;^UTILITY(U,$J,358.3,33065,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,33065,1,3,0)
+82 ;;=3^Viral hepatitis C with hepatic coma,Unspec
+83 ;;^UTILITY(U,$J,358.3,33065,1,4,0)
+84 ;;=4^B19.21
+85 ;;^UTILITY(U,$J,358.3,33065,2)
+86 ;;=^331437
+87 ;;^UTILITY(U,$J,358.3,33066,0)
+88 ;;=C22.0^^102^1378^16
+89 ;;^UTILITY(U,$J,358.3,33066,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,33066,1,3,0)
+92 ;;=3^Liver cell carcinoma
+93 ;;^UTILITY(U,$J,358.3,33066,1,4,0)
+94 ;;=4^C22.0
+95 ;;^UTILITY(U,$J,358.3,33066,2)
+96 ;;=^5000933
+97 ;;^UTILITY(U,$J,358.3,33067,0)
+98 ;;=C22.7^^102^1378^8
+99 ;;^UTILITY(U,$J,358.3,33067,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,33067,1,3,0)
+102 ;;=3^Carcinomas of liver NEC
+103 ;;^UTILITY(U,$J,358.3,33067,1,4,0)
+104 ;;=4^C22.7
+105 ;;^UTILITY(U,$J,358.3,33067,2)
+106 ;;=^5000938
+107 ;;^UTILITY(U,$J,358.3,33068,0)
+108 ;;=C22.8^^102^1378^19
+109 ;;^UTILITY(U,$J,358.3,33068,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,33068,1,3,0)
+112 ;;=3^Malignant neoplasm of liver, primary
+113 ;;^UTILITY(U,$J,358.3,33068,1,4,0)
+114 ;;=4^C22.8
+115 ;;^UTILITY(U,$J,358.3,33068,2)
+116 ;;=^5000939
+117 ;;^UTILITY(U,$J,358.3,33069,0)
+118 ;;=C22.1^^102^1378^14
+119 ;;^UTILITY(U,$J,358.3,33069,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,33069,1,3,0)
+122 ;;=3^Intrahepatic bile duct carcinoma
+123 ;;^UTILITY(U,$J,358.3,33069,1,4,0)
+124 ;;=4^C22.1
+125 ;;^UTILITY(U,$J,358.3,33069,2)
+126 ;;=^5000934
+127 ;;^UTILITY(U,$J,358.3,33070,0)
+128 ;;=C22.9^^102^1378^18
+129 ;;^UTILITY(U,$J,358.3,33070,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,33070,1,3,0)
+132 ;;=3^Malignant neoplasm of liver
+133 ;;^UTILITY(U,$J,358.3,33070,1,4,0)
+134 ;;=4^C22.9
+135 ;;^UTILITY(U,$J,358.3,33070,2)
+136 ;;=^267096
+137 ;;^UTILITY(U,$J,358.3,33071,0)
+138 ;;=C78.7^^102^1378^22
+139 ;;^UTILITY(U,$J,358.3,33071,1,0)
+140 ;;=^358.31IA^4^2
+141 ;;^UTILITY(U,$J,358.3,33071,1,3,0)
+142 ;;=3^Secondary malig neoplasm of liver and intrahepatic bile duct
+143 ;;^UTILITY(U,$J,358.3,33071,1,4,0)
+144 ;;=4^C78.7
+145 ;;^UTILITY(U,$J,358.3,33071,2)
+146 ;;=^5001339
+147 ;;^UTILITY(U,$J,358.3,33072,0)
+148 ;;=K74.60^^102^1378^12
+149 ;;^UTILITY(U,$J,358.3,33072,1,0)
+150 ;;=^358.31IA^4^2
+151 ;;^UTILITY(U,$J,358.3,33072,1,3,0)
+152 ;;=3^Cirrhosis of liver,Unspec
+153 ;;^UTILITY(U,$J,358.3,33072,1,4,0)
+154 ;;=4^K74.60
+155 ;;^UTILITY(U,$J,358.3,33072,2)
+156 ;;=^5008822
+157 ;;^UTILITY(U,$J,358.3,33073,0)
+158 ;;=K76.0^^102^1378^13
+159 ;;^UTILITY(U,$J,358.3,33073,1,0)
+160 ;;=^358.31IA^4^2
+161 ;;^UTILITY(U,$J,358.3,33073,1,3,0)
+162 ;;=3^Fatty (change of) liver, not elsewhere classified
+163 ;;^UTILITY(U,$J,358.3,33073,1,4,0)
+164 ;;=4^K76.0
+165 ;;^UTILITY(U,$J,358.3,33073,2)
+166 ;;=^5008831
+167 ;;^UTILITY(U,$J,358.3,33074,0)
+168 ;;=K76.89^^102^1378^15
+169 ;;^UTILITY(U,$J,358.3,33074,1,0)
+170 ;;=^358.31IA^4^2
+171 ;;^UTILITY(U,$J,358.3,33074,1,3,0)
+172 ;;=3^Liver Disease NEC
+173 ;;^UTILITY(U,$J,358.3,33074,1,4,0)
+174 ;;=4^K76.89
+175 ;;^UTILITY(U,$J,358.3,33074,2)
+176 ;;=^5008835
+177 ;;^UTILITY(U,$J,358.3,33075,0)
+178 ;;=K70.30^^102^1378^6
+179 ;;^UTILITY(U,$J,358.3,33075,1,0)
+180 ;;=^358.31IA^4^2
+181 ;;^UTILITY(U,$J,358.3,33075,1,3,0)
+182 ;;=3^Alcoholic cirrhosis of liver without ascites
+183 ;;^UTILITY(U,$J,358.3,33075,1,4,0)
+184 ;;=4^K70.30
+185 ;;^UTILITY(U,$J,358.3,33075,2)
+186 ;;=^5008788
+187 ;;^UTILITY(U,$J,358.3,33076,0)
+188 ;;=K70.31^^102^1378^5
+189 ;;^UTILITY(U,$J,358.3,33076,1,0)
+190 ;;=^358.31IA^4^2
+191 ;;^UTILITY(U,$J,358.3,33076,1,3,0)
+192 ;;=3^Alcoholic cirrhosis of liver with ascites
+193 ;;^UTILITY(U,$J,358.3,33076,1,4,0)
+194 ;;=4^K70.31
+195 ;;^UTILITY(U,$J,358.3,33076,2)
+196 ;;=^5008789
+197 ;;^UTILITY(U,$J,358.3,33077,0)
+198 ;;=K75.4^^102^1378^7
+199 ;;^UTILITY(U,$J,358.3,33077,1,0)
+200 ;;=^358.31IA^4^2
+201 ;;^UTILITY(U,$J,358.3,33077,1,3,0)
+202 ;;=3^Autoimmune hepatitis
+203 ;;^UTILITY(U,$J,358.3,33077,1,4,0)
+204 ;;=4^K75.4
+205 ;;^UTILITY(U,$J,358.3,33077,2)
+206 ;;=^336610
+207 ;;^UTILITY(U,$J,358.3,33078,0)
+208 ;;=K74.69^^102^1378^11
+209 ;;^UTILITY(U,$J,358.3,33078,1,0)
+210 ;;=^358.31IA^4^2
+211 ;;^UTILITY(U,$J,358.3,33078,1,3,0)
+212 ;;=3^Cirrhosis of liver NEC
+213 ;;^UTILITY(U,$J,358.3,33078,1,4,0)
+214 ;;=4^K74.69
+215 ;;^UTILITY(U,$J,358.3,33078,2)
+216 ;;=^5008823
+217 ;;^UTILITY(U,$J,358.3,33079,0)
+218 ;;=K74.3^^102^1378^21
+219 ;;^UTILITY(U,$J,358.3,33079,1,0)
+220 ;;=^358.31IA^4^2
+221 ;;^UTILITY(U,$J,358.3,33079,1,3,0)
+222 ;;=3^Primary biliary cirrhosis
+223 ;;^UTILITY(U,$J,358.3,33079,1,4,0)
+224 ;;=4^K74.3
+225 ;;^UTILITY(U,$J,358.3,33079,2)
+226 ;;=^5008819
+227 ;;^UTILITY(U,$J,358.3,33080,0)
+228 ;;=K75.81^^102^1378^20
+229 ;;^UTILITY(U,$J,358.3,33080,1,0)
+230 ;;=^358.31IA^4^2
+231 ;;^UTILITY(U,$J,358.3,33080,1,3,0)
+232 ;;=3^Nonalcoholic steatohepatitis (NASH)
+233 ;;^UTILITY(U,$J,358.3,33080,1,4,0)
+234 ;;=4^K75.81
+235 ;;^UTILITY(U,$J,358.3,33080,2)
+236 ;;=K830^5008828
+237 ;;^UTILITY(U,$J,358.3,33081,0)
+238 ;;=B16.9^^102^1378^1
+239 ;;^UTILITY(U,$J,358.3,33081,1,0)
+240 ;;=^358.31IA^4^2
+241 ;;^UTILITY(U,$J,358.3,33081,1,3,0)
+242 ;;=3^Acute hepatitis B w/o delta-agent and without hepatic coma
+243 ;;^UTILITY(U,$J,358.3,33081,1,4,0)
+244 ;;=4^B16.9
+245 ;;^UTILITY(U,$J,358.3,33081,2)
+246 ;;=^5000540
+247 ;;^UTILITY(U,$J,358.3,33082,0)
+248 ;;=B18.1^^102^1378^9
+249 ;;^UTILITY(U,$J,358.3,33082,1,0)
+250 ;;=^358.31IA^4^2
+251 ;;^UTILITY(U,$J,358.3,33082,1,3,0)
+252 ;;=3^Chronic viral hepatitis B without delta-agent
+253 ;;^UTILITY(U,$J,358.3,33082,1,4,0)
+254 ;;=4^B18.1
+255 ;;^UTILITY(U,$J,358.3,33082,2)
+256 ;;=^5000547
+257 ;;^UTILITY(U,$J,358.3,33083,0)
+258 ;;=Z94.4^^102^1378^17
+259 ;;^UTILITY(U,$J,358.3,33083,1,0)
+260 ;;=^358.31IA^4^2
+261 ;;^UTILITY(U,$J,358.3,33083,1,3,0)
+262 ;;=3^Liver transplant status
+263 ;;^UTILITY(U,$J,358.3,33083,1,4,0)
+264 ;;=4^Z94.4
+265 ;;^UTILITY(U,$J,358.3,33083,2)
+266 ;;=^5063658
+267 ;;^UTILITY(U,$J,358.3,33084,0)
+268 ;;=Z48.23^^102^1378^4
+269 ;;^UTILITY(U,$J,358.3,33084,1,0)
+270 ;;=^358.31IA^4^2
+271 ;;^UTILITY(U,$J,358.3,33084,1,3,0)
+272 ;;=3^Aftercare Following Liver Transplant
+273 ;;^UTILITY(U,$J,358.3,33084,1,4,0)
+274 ;;=4^Z48.23
+275 ;;^UTILITY(U,$J,358.3,33084,2)
+276 ;;=^5063040
+277 ;;^UTILITY(U,$J,358.3,33085,0)
+278 ;;=J90.^^102^1379^16
+279 ;;^UTILITY(U,$J,358.3,33085,1,0)
+280 ;;=^358.31IA^4^2
+281 ;;^UTILITY(U,$J,358.3,33085,1,3,0)
+282 ;;=3^Pleural effusion, not elsewhere classified
+283 ;;^UTILITY(U,$J,358.3,33085,1,4,0)
+284 ;;=4^J90.
+285 ;;^UTILITY(U,$J,358.3,33085,2)
+286 ;;=^5008310
+287 ;;^UTILITY(U,$J,358.3,33086,0)
+288 ;;=C34.91^^102^1379^13
+289 ;;^UTILITY(U,$J,358.3,33086,1,0)
+290 ;;=^358.31IA^4^2
+291 ;;^UTILITY(U,$J,358.3,33086,1,3,0)
+292 ;;=3^Malignant neoplasm of unsp part of right bronchus or lung
+293 ;;^UTILITY(U,$J,358.3,33086,1,4,0)
+294 ;;=4^C34.91
+295 ;;^UTILITY(U,$J,358.3,33086,2)
+296 ;;=^5000967
+297 ;;^UTILITY(U,$J,358.3,33087,0)
+298 ;;=C34.92^^102^1379^12
+299 ;;^UTILITY(U,$J,358.3,33087,1,0)
+300 ;;=^358.31IA^4^2
+301 ;;^UTILITY(U,$J,358.3,33087,1,3,0)
+302 ;;=3^Malignant neoplasm of unsp part of left bronchus or lung
+303 ;;^UTILITY(U,$J,358.3,33087,1,4,0)
+304 ;;=4^C34.92
+305 ;;^UTILITY(U,$J,358.3,33087,2)
+306 ;;=^5000968
+307 ;;^UTILITY(U,$J,358.3,33088,0)
+308 ;;=C34.01^^102^1379^11
+309 ;;^UTILITY(U,$J,358.3,33088,1,0)
+310 ;;=^358.31IA^4^2
+311 ;;^UTILITY(U,$J,358.3,33088,1,3,0)
+312 ;;=3^Malignant neoplasm of right main bronchus
+313 ;;^UTILITY(U,$J,358.3,33088,1,4,0)
+314 ;;=4^C34.01
+315 ;;^UTILITY(U,$J,358.3,33088,2)
+316 ;;=^5000958
+317 ;;^UTILITY(U,$J,358.3,33089,0)
+318 ;;=C34.02^^102^1379^5
+319 ;;^UTILITY(U,$J,358.3,33089,1,0)
+320 ;;=^358.31IA^4^2
+321 ;;^UTILITY(U,$J,358.3,33089,1,3,0)
+322 ;;=3^Malignant neoplasm of left main bronchus
+323 ;;^UTILITY(U,$J,358.3,33089,1,4,0)
+324 ;;=4^C34.02
+325 ;;^UTILITY(U,$J,358.3,33089,2)
+326 ;;=^5000959
+327 ;;^UTILITY(U,$J,358.3,33090,0)
+328 ;;=C34.11^^102^1379^15
+329 ;;^UTILITY(U,$J,358.3,33090,1,0)
+330 ;;=^358.31IA^4^2
+331 ;;^UTILITY(U,$J,358.3,33090,1,3,0)
+332 ;;=3^Malignant neoplasm of upper lobe, right bronchus or lung
+333 ;;^UTILITY(U,$J,358.3,33090,1,4,0)
+334 ;;=4^C34.11
+335 ;;^UTILITY(U,$J,358.3,33090,2)
+336 ;;=^5000961
+337 ;;^UTILITY(U,$J,358.3,33091,0)
+338 ;;=C34.12^^102^1379^14
+339 ;;^UTILITY(U,$J,358.3,33091,1,0)
+340 ;;=^358.31IA^4^2
+341 ;;^UTILITY(U,$J,358.3,33091,1,3,0)
+342 ;;=3^Malignant neoplasm of upper lobe, left bronchus or lung
+343 ;;^UTILITY(U,$J,358.3,33091,1,4,0)
+344 ;;=4^C34.12
+345 ;;^UTILITY(U,$J,358.3,33091,2)
+346 ;;=^5000962
+347 ;;^UTILITY(U,$J,358.3,33092,0)
+348 ;;=C34.2^^102^1379^8
+349 ;;^UTILITY(U,$J,358.3,33092,1,0)
+350 ;;=^358.31IA^4^2
+351 ;;^UTILITY(U,$J,358.3,33092,1,3,0)
+352 ;;=3^Malignant neoplasm of middle lobe, bronchus or lung
+353 ;;^UTILITY(U,$J,358.3,33092,1,4,0)
+354 ;;=4^C34.2
+355 ;;^UTILITY(U,$J,358.3,33092,2)
+356 ;;=^267137
+357 ;;^UTILITY(U,$J,358.3,33093,0)
+358 ;;=C34.31^^102^1379^7
+359 ;;^UTILITY(U,$J,358.3,33093,1,0)
+360 ;;=^358.31IA^4^2
+361 ;;^UTILITY(U,$J,358.3,33093,1,3,0)
+362 ;;=3^Malignant neoplasm of lower lobe, right bronchus or lung
+363 ;;^UTILITY(U,$J,358.3,33093,1,4,0)
+364 ;;=4^C34.31
+365 ;;^UTILITY(U,$J,358.3,33093,2)
+366 ;;=^5133321
+367 ;;^UTILITY(U,$J,358.3,33094,0)
+368 ;;=C34.32^^102^1379^6
+369 ;;^UTILITY(U,$J,358.3,33094,1,0)
+370 ;;=^358.31IA^4^2
+371 ;;^UTILITY(U,$J,358.3,33094,1,3,0)
+372 ;;=3^Malignant neoplasm of lower lobe, left bronchus or lung
+373 ;;^UTILITY(U,$J,358.3,33094,1,4,0)
+374 ;;=4^C34.32
+375 ;;^UTILITY(U,$J,358.3,33094,2)
+376 ;;=^5133322
+377 ;;^UTILITY(U,$J,358.3,33095,0)
+378 ;;=C34.81^^102^1379^10
+379 ;;^UTILITY(U,$J,358.3,33095,1,0)
+380 ;;=^358.31IA^4^2
+381 ;;^UTILITY(U,$J,358.3,33095,1,3,0)
+382 ;;=3^Malignant neoplasm of ovrlp sites of right bronchus and lung
+383 ;;^UTILITY(U,$J,358.3,33095,1,4,0)
+384 ;;=4^C34.81
+385 ;;^UTILITY(U,$J,358.3,33095,2)
+386 ;;=^5000964
+387 ;;^UTILITY(U,$J,358.3,33096,0)
+388 ;;=C34.82^^102^1379^9
+389 ;;^UTILITY(U,$J,358.3,33096,1,0)
+390 ;;=^358.31IA^4^2
+391 ;;^UTILITY(U,$J,358.3,33096,1,3,0)
+392 ;;=3^Malignant neoplasm of ovrlp sites of left bronchus and lung
+393 ;;^UTILITY(U,$J,358.3,33096,1,4,0)
+394 ;;=4^C34.82
+395 ;;^UTILITY(U,$J,358.3,33096,2)
+396 ;;=^5000965
+397 ;;^UTILITY(U,$J,358.3,33097,0)
+398 ;;=Z48.24^^102^1379^2
+399 ;;^UTILITY(U,$J,358.3,33097,1,0)
+400 ;;=^358.31IA^4^2
+401 ;;^UTILITY(U,$J,358.3,33097,1,3,0)
+402 ;;=3^Aftercare Following Lung Transplant
+403 ;;^UTILITY(U,$J,358.3,33097,1,4,0)
+404 ;;=4^Z48.24
+405 ;;^UTILITY(U,$J,358.3,33097,2)
+406 ;;=^5063041
+407 ;;^UTILITY(U,$J,358.3,33098,0)
+408 ;;=Z48.280^^102^1379^1
+409 ;;^UTILITY(U,$J,358.3,33098,1,0)
+410 ;;=^358.31IA^4^2
+411 ;;^UTILITY(U,$J,358.3,33098,1,3,0)
+412 ;;=3^Aftercare Following Heart & Lung Transplant
+413 ;;^UTILITY(U,$J,358.3,33098,1,4,0)
+414 ;;=4^Z48.280
+415 ;;^UTILITY(U,$J,358.3,33098,2)
+416 ;;=^5063042
+417 ;;^UTILITY(U,$J,358.3,33099,0)
+418 ;;=Z94.3^^102^1379^3
+419 ;;^UTILITY(U,$J,358.3,33099,1,0)
+420 ;;=^358.31IA^4^2
+421 ;;^UTILITY(U,$J,358.3,33099,1,3,0)
+422 ;;=3^Heart & Lungs Transplant Status
+423 ;;^UTILITY(U,$J,358.3,33099,1,4,0)
+424 ;;=4^Z94.3
+425 ;;^UTILITY(U,$J,358.3,33099,2)
+426 ;;=^5063657
+427 ;;^UTILITY(U,$J,358.3,33100,0)
+428 ;;=Z94.2^^102^1379^4
+429 ;;^UTILITY(U,$J,358.3,33100,1,0)
+430 ;;=^358.31IA^4^2
+431 ;;^UTILITY(U,$J,358.3,33100,1,3,0)
+432 ;;=3^Lung Transplant Status
+433 ;;^UTILITY(U,$J,358.3,33100,1,4,0)
+434 ;;=4^Z94.2
+435 ;;^UTILITY(U,$J,358.3,33100,2)
+436 ;;=^5063656
+437 ;;^UTILITY(U,$J,358.3,33101,0)
+438 ;;=C83.38^^102^1380^22
+439 ;;^UTILITY(U,$J,358.3,33101,1,0)
+440 ;;=^358.31IA^4^2
+441 ;;^UTILITY(U,$J,358.3,33101,1,3,0)
+442 ;;=3^Diffuse large B-cell lymphoma, lymph nodes of multiple sites
+443 ;;^UTILITY(U,$J,358.3,33101,1,4,0)
+444 ;;=4^C83.38
+445 ;;^UTILITY(U,$J,358.3,33101,2)
+446 ;;=^5001579
+447 ;;^UTILITY(U,$J,358.3,33102,0)
+448 ;;=C83.58^^102^1380^28
+449 ;;^UTILITY(U,$J,358.3,33102,1,0)
+450 ;;=^358.31IA^4^2
+451 ;;^UTILITY(U,$J,358.3,33102,1,3,0)
+452 ;;=3^Lymphoblastic (diffuse) lymphoma, lymph nodes mult site
+453 ;;^UTILITY(U,$J,358.3,33102,1,4,0)
+454 ;;=4^C83.58
+455 ;;^UTILITY(U,$J,358.3,33102,2)
+456 ;;=^5001589
+457 ;;^UTILITY(U,$J,358.3,33103,0)
+458 ;;=C83.78^^102^1380^15
+459 ;;^UTILITY(U,$J,358.3,33103,1,0)
+460 ;;=^358.31IA^4^2
+461 ;;^UTILITY(U,$J,358.3,33103,1,3,0)
+462 ;;=3^Burkitt lymphoma, lymph nodes of multiple sites
+463 ;;^UTILITY(U,$J,358.3,33103,1,4,0)
+464 ;;=4^C83.78
+465 ;;^UTILITY(U,$J,358.3,33103,2)
+466 ;;=^5001599
+467 ;;^UTILITY(U,$J,358.3,33104,0)
+468 ;;=C83.18^^102^1380^34
+469 ;;^UTILITY(U,$J,358.3,33104,1,0)
+470 ;;=^358.31IA^4^2
+471 ;;^UTILITY(U,$J,358.3,33104,1,3,0)
+472 ;;=3^Mantle cell lymphoma, lymph nodes of multiple sites
+473 ;;^UTILITY(U,$J,358.3,33104,1,4,0)
+474 ;;=4^C83.18
+475 ;;^UTILITY(U,$J,358.3,33104,2)
+476 ;;=^5001569
+477 ;;^UTILITY(U,$J,358.3,33105,0)
+478 ;;=C84.68^^102^1380^12
+479 ;;^UTILITY(U,$J,358.3,33105,1,0)
+480 ;;=^358.31IA^4^2
+481 ;;^UTILITY(U,$J,358.3,33105,1,3,0)
+482 ;;=3^Anaplastic large cell lymphoma, ALK-pos, nodes mult site
+483 ;;^UTILITY(U,$J,358.3,33105,1,4,0)
+484 ;;=4^C84.68
+485 ;;^UTILITY(U,$J,358.3,33105,2)
+486 ;;=^5001659
+487 ;;^UTILITY(U,$J,358.3,33106,0)
+488 ;;=C84.78^^102^1380^11
+489 ;;^UTILITY(U,$J,358.3,33106,1,0)
+490 ;;=^358.31IA^4^2
+491 ;;^UTILITY(U,$J,358.3,33106,1,3,0)
+492 ;;=3^Anaplastic large cell lymphoma, ALK-neg, nodes mult site
+493 ;;^UTILITY(U,$J,358.3,33106,1,4,0)
+494 ;;=4^C84.78
+495 ;;^UTILITY(U,$J,358.3,33106,2)
+496 ;;=^5001669
+497 ;;^UTILITY(U,$J,358.3,33107,0)
+498 ;;=C81.08^^102^1380^47
+499 ;;^UTILITY(U,$J,358.3,33107,1,0)
+500 ;;=^358.31IA^4^2
+501 ;;^UTILITY(U,$J,358.3,33107,1,3,0)
+502 ;;=3^Nodular lymphocyte predom Hodgkin lymphoma, nodes mult site
+503 ;;^UTILITY(U,$J,358.3,33107,1,4,0)
+504 ;;=4^C81.08
+505 ;;^UTILITY(U,$J,358.3,33107,2)
+506 ;;=^5001399
+507 ;;^UTILITY(U,$J,358.3,33108,0)
+508 ;;=C81.48^^102^1380^27
+509 ;;^UTILITY(U,$J,358.3,33108,1,0)
+510 ;;=^358.31IA^4^2
+511 ;;^UTILITY(U,$J,358.3,33108,1,3,0)
+512 ;;=3^Lymp-rich classical Hodgkin lymphoma, lymph nodes mult site
+513 ;;^UTILITY(U,$J,358.3,33108,1,4,0)
+514 ;;=4^C81.48
+515 ;;^UTILITY(U,$J,358.3,33108,2)
+516 ;;=^5001439
+517 ;;^UTILITY(U,$J,358.3,33109,0)
+518 ;;=C81.18^^102^1380^48
+519 ;;^UTILITY(U,$J,358.3,33109,1,0)
+520 ;;=^358.31IA^4^2
+521 ;;^UTILITY(U,$J,358.3,33109,1,3,0)
+522 ;;=3^Nodular sclerosis class Hodgkin lymphoma, nodes mult site
+523 ;;^UTILITY(U,$J,358.3,33109,1,4,0)
+524 ;;=4^C81.18
+525 ;;^UTILITY(U,$J,358.3,33109,2)
+526 ;;=^5001409
+527 ;;^UTILITY(U,$J,358.3,33110,0)
+528 ;;=C81.28^^102^1380^38
+529 ;;^UTILITY(U,$J,358.3,33110,1,0)
+530 ;;=^358.31IA^4^2
+531 ;;^UTILITY(U,$J,358.3,33110,1,3,0)
+532 ;;=3^Mixed cellular classical Hodgkin lymphoma, nodes mult site
+533 ;;^UTILITY(U,$J,358.3,33110,1,4,0)
+534 ;;=4^C81.28
+535 ;;^UTILITY(U,$J,358.3,33110,2)
+536 ;;=^5001419
+537 ;;^UTILITY(U,$J,358.3,33111,0)
+538 ;;=C81.38^^102^1380^29
+539 ;;^UTILITY(U,$J,358.3,33111,1,0)
+540 ;;=^358.31IA^4^2
+541 ;;^UTILITY(U,$J,358.3,33111,1,3,0)
+542 ;;=3^Lymphocy depleted class Hodgkin lymphoma, nodes mult site
+543 ;;^UTILITY(U,$J,358.3,33111,1,4,0)
+544 ;;=4^C81.38
+545 ;;^UTILITY(U,$J,358.3,33111,2)
+546 ;;=^5001429
+547 ;;^UTILITY(U,$J,358.3,33112,0)
+548 ;;=C82.98^^102^1380^25
+549 ;;^UTILITY(U,$J,358.3,33112,1,0)
+550 ;;=^358.31IA^4^2
+551 ;;^UTILITY(U,$J,358.3,33112,1,3,0)
+552 ;;=3^Follicular lymphoma, unsp, lymph nodes of multiple sites
+553 ;;^UTILITY(U,$J,358.3,33112,1,4,0)
+554 ;;=4^C82.98
+555 ;;^UTILITY(U,$J,358.3,33112,2)
+556 ;;=^5001549
+557 ;;^UTILITY(U,$J,358.3,33113,0)
+558 ;;=C84.08^^102^1380^44
+559 ;;^UTILITY(U,$J,358.3,33113,1,0)
+560 ;;=^358.31IA^4^2
+561 ;;^UTILITY(U,$J,358.3,33113,1,3,0)
+562 ;;=3^Mycosis fungoides, lymph nodes of multiple sites
+563 ;;^UTILITY(U,$J,358.3,33113,1,4,0)
+564 ;;=4^C84.08
+565 ;;^UTILITY(U,$J,358.3,33113,2)
+566 ;;=^5001629
+567 ;;^UTILITY(U,$J,358.3,33114,0)
+568 ;;=C84.18^^102^1380^53
+569 ;;^UTILITY(U,$J,358.3,33114,1,0)
+570 ;;=^358.31IA^4^2
+571 ;;^UTILITY(U,$J,358.3,33114,1,3,0)
+572 ;;=3^Sezary disease, lymph nodes of multiple sites
+573 ;;^UTILITY(U,$J,358.3,33114,1,4,0)
+574 ;;=4^C84.18
+575 ;;^UTILITY(U,$J,358.3,33114,2)
+576 ;;=^5001639
+577 ;;^UTILITY(U,$J,358.3,33115,0)
+578 ;;=C91.40^^102^1380^26
+579 ;;^UTILITY(U,$J,358.3,33115,1,0)
+580 ;;=^358.31IA^4^2
+581 ;;^UTILITY(U,$J,358.3,33115,1,3,0)
+582 ;;=3^Hairy cell leukemia not having achieved remission
+583 ;;^UTILITY(U,$J,358.3,33115,1,4,0)
+584 ;;=4^C91.40
+585 ;;^UTILITY(U,$J,358.3,33115,2)
+586 ;;=^5001771
+587 ;;^UTILITY(U,$J,358.3,33116,0)
+588 ;;=C96.0^^102^1380^41
+589 ;;^UTILITY(U,$J,358.3,33116,1,0)
+590 ;;=^358.31IA^4^2
+591 ;;^UTILITY(U,$J,358.3,33116,1,3,0)
+592 ;;=3^Multifocal and multisystemic Langerhans-cell histiocytosis
+593 ;;^UTILITY(U,$J,358.3,33116,1,4,0)
+594 ;;=4^C96.0
+595 ;;^UTILITY(U,$J,358.3,33116,2)
+596 ;;=^5001859
+597 ;;^UTILITY(U,$J,358.3,33117,0)
+598 ;;=C84.48^^102^1380^49
+599 ;;^UTILITY(U,$J,358.3,33117,1,0)
+600 ;;=^358.31IA^4^2
+601 ;;^UTILITY(U,$J,358.3,33117,1,3,0)
+602 ;;=3^Peripheral T-cell lymphoma, not classified, nodes mult site
+603 ;;^UTILITY(U,$J,358.3,33117,1,4,0)
+604 ;;=4^C84.48
+605 ;;^UTILITY(U,$J,358.3,33117,2)
+606 ;;=^5001649
+607 ;;^UTILITY(U,$J,358.3,33118,0)
+608 ;;=C90.01^^102^1380^43
+609 ;;^UTILITY(U,$J,358.3,33118,1,0)
+610 ;;=^358.31IA^4^2
+611 ;;^UTILITY(U,$J,358.3,33118,1,3,0)
+612 ;;=3^Multiple myeloma in remission
+613 ;;^UTILITY(U,$J,358.3,33118,1,4,0)
+614 ;;=4^C90.01
+615 ;;^UTILITY(U,$J,358.3,33118,2)
+616 ;;=^267515
+617 ;;^UTILITY(U,$J,358.3,33119,0)
+618 ;;=C90.02^^102^1380^42
+619 ;;^UTILITY(U,$J,358.3,33119,1,0)
+620 ;;=^358.31IA^4^2
+621 ;;^UTILITY(U,$J,358.3,33119,1,3,0)
+622 ;;=3^Multiple myeloma in relapse
+623 ;;^UTILITY(U,$J,358.3,33119,1,4,0)
+624 ;;=4^C90.02
+625 ;;^UTILITY(U,$J,358.3,33119,2)
+626 ;;=^5001753
+627 ;;^UTILITY(U,$J,358.3,33120,0)
+628 ;;=C90.11^^102^1380^51
+629 ;;^UTILITY(U,$J,358.3,33120,1,0)
+630 ;;=^358.31IA^4^2
+631 ;;^UTILITY(U,$J,358.3,33120,1,3,0)
+632 ;;=3^Plasma cell leukemia in remission
+633 ;;^UTILITY(U,$J,358.3,33120,1,4,0)
+634 ;;=4^C90.11
+635 ;;^UTILITY(U,$J,358.3,33120,2)
+636 ;;=^267517
+637 ;;^UTILITY(U,$J,358.3,33121,0)
+638 ;;=C90.12^^102^1380^50
+639 ;;^UTILITY(U,$J,358.3,33121,1,0)
+640 ;;=^358.31IA^4^2
+641 ;;^UTILITY(U,$J,358.3,33121,1,3,0)
+642 ;;=3^Plasma cell leukemia in relapse
+643 ;;^UTILITY(U,$J,358.3,33121,1,4,0)
+644 ;;=4^C90.12
+645 ;;^UTILITY(U,$J,358.3,33121,2)
+646 ;;=^5001755
+647 ;;^UTILITY(U,$J,358.3,33122,0)
+648 ;;=C90.21^^102^1380^24
+649 ;;^UTILITY(U,$J,358.3,33122,1,0)
+650 ;;=^358.31IA^4^2
+651 ;;^UTILITY(U,$J,358.3,33122,1,3,0)
+652 ;;=3^Extramedullary plasmacytoma in remission
+653 ;;^UTILITY(U,$J,358.3,33122,1,4,0)
+654 ;;=4^C90.21
+655 ;;^UTILITY(U,$J,358.3,33122,2)
+656 ;;=^5001757
+657 ;;^UTILITY(U,$J,358.3,33123,0)
+658 ;;=C90.31^^102^1380^55
